Career Support Grants

Previous outcomes

Here you can find details of the outcomes of past and currently funded grants in this program stream.

2020

Career Development Fellowships

Administering Institution Grantee Grant Title Funding (excl. GST)

Cancer Council NSW

Dr Kate Simms Evaluating Novel Interventions To Facilitate Cervical Cancer Elimination Across Low-And-Middle-Income Countries And High-Income Countries: A Modelled Evaluation.

$564,136

University of New South Wales

Dr Maarit Laaksonen

Improving cancer prevention, early detection and outcomes through novel applications of cancer burden methods to large linked health data.

$150,000

University of New South Wales

Dr Wei Deng

New therapeutic option for lymph node metastasis in rectal cancer: radiation-triggered photodynamic therapy in deep tissue.

 $517,454

$1,231,590


Early Career Fellowships

Administering Institution Grantee Grant Title Funding (excl. GST)

University of New South Wales

Dr Anthony Glover

The Endocrine Cancer Research Program

$540,000

University of New South Wales

Dr Natalia Castano Rodriguez

Understanding the tumour-promoting functions of autophagy in gastric carcinogenesis

$598,636

The University of Sydney

Dr Paul Zhi Yuan Liu

Upright radiotherapy for improved lung cancer treatment outcomes

$355,000

The University of Sydney

Dr David Waddington

Personalising cancer radiation therapy via dynamic MRI-based adaptation to changing tumour anatomy and biology

$583,100

$2,076,736

 

2019

Career Development Fellowships

Administering Institution Grantee Grant Title Funding (excl. GST)

The University of Sydney

Dr Lake-Ee Quek Exploiting vulnerabilities of prostate cancer lipid metabolism with precision: the use of stable isotope lipidomics to guide treatment strategy

$455,000

University of New South Wales

Dr Michelle McDonald

Tumour-bone cell interactions: An opportunity to harness the microenvironment to overcome metastatic disease

 $599,920

University of New South Wales

Dr Christine Chaffer

Manipulating IL-1b/IL-1R1 signalling to inhibit breast cancer metastasis.

 $600,000

University of New South Wales

Dr Ozren Bogdanovic

Epigenetic regulation of germline cell fate during oncogenesis

 $410,000

University of New South Wales

Dr Fatima Valdes Mora

An epigenetic approach to target akuma-myeloid-derived suppressor cells in breast cancer

 $600,000

University of Newcastle

Dr Kelly Avery-Kiejda

Development of a predictive test for p53 and its isoforms to aid the clinical treatment of breast cancer

 $552,460

University of New South Wales

Dr Mark McCabe

Non-invasive monitoring of tumour burden and therapeutic response through liquid biopsy and targeted gene capture

 $600,000

University of New South Wales

Dr George Sharbeen

A novel multi-cellular therapeutic approach targeting DNA repair in pancreatic cancer

 $150,000

University of Sydney

Dr Danuta Kalinowski

An Innovative Pharmacological Approach: The Development of Multi-Targeted Cancer Therapeutics

 $150,000

$4,117,380


Early Career Fellowships

Administering Institution Grantee Grant Title Funding (excl. GST)

The University of Sydney

Dr Emily Blyth

Development and clinical implementation of adoptive T cell therapies for haematological malignancies

$480,000

University of New South Wales

Dr Andre Minoche

Defining the genomic and epigenetic landscape of high-risk paediatric cancer genomes using long-read sequencing

$508,231

Cancer Council NSW

Dr Megan Smith

Optimising and Successfully Implementing Cervical Cancer Prevention Policies

$233,060

University of New South Wales

Dr Marion Mateos

Clinical and genomic characteristics associated with symptomatic and severe venous thromboembolism in acute lymphoblastic leukaemia

$425,673

University of New South Wales

Dr Matthew Field

Improving lung cancer outcomes with data-driven prognostic imaging biomarkers in a collaborative medical imaging network

 $420,246

University of New South Wales

Dr Lin Xiao

Mechanisms of CBL0137 and Panobinostat Interaction Underlying Their Curative Action in Neuroblastoma

 $592,658

The University of Sydney

Mr Pascal Steffen

Investigating the prognostic contribution of immune cell infiltration in rectal cancer

 $600,000

University of New South Wales

Dr Michael Jameson

ImproviNg brain cancer ouTcomes with mRi guidEd adaPtIve raDiotherapy (INTREPID)

 $480,000

University of Newcastle

Dr Danny Lee

MIRACLE (4D-MRI In Radiotherapy for AChieving tumour Localisation and Effective treatment)

 $548,377

University of Newcastle

Dr Elizabeth Fradgley

A multi-component implementation strategy to improve the evidence-based distress management practices of Australian cancer services: the effectiveness and cost of online Training and EducatioNal OutReach visits (The TENOR Trial)

 $597,166

Macquarie University

Dr Rebeca Sakuma

Colorectal Cancer Glycobiology: Unexpected Players In Epithelial-Mesenchymal Transition And Inflammation

 $599,997

$5,485,408

2018

Career Development Fellowships

Administering Institution Grantee Grant Title Funding (excl. GST)

Garvan Institute of Medical Research

Dr Mandy Ballinger

A Clinical Genomics Program focused on Early Onset Cancers

$600,000

Garvan Institute of Medical Research

Dr Thomas Cox

Transient tissue ‘priming’ as a therapeutic modality to impair pancreatic cancer progression and improve sensitivity to adjuvant therapies

$341,667

The University of Sydney

Dr Patric Jansson

Development of Innovative Chemotherapeutics that Target P-Glycoprotein-Expressing Cancers to Overcome Drug Resistance

$150,000

The University of Sydney

Dr Zaklina Kovacevic

Overcoming breast cancer heterogeneity and resistance using a novel therapeutic approach targeting the metastasis suppressor NDRG1

$75,000

The University of Sydney

Associate Professor Ricky O'Brien

The Clinical Translation of NSW Invented Tumour Motion Management Technologies in Cancer Radiotherapy

$600,000

The University of Sydney

Dr Justin Jong-Leong Wong

Defining the role of aberrant splicing (intron retention) in the development and maintenance of acute myeloid leukaemia

$150,000

$1,916,667

Early Career Fellowships

Administering Institution Grantee Grant Title Funding (excl. GST)

Garvan Institute of Medical Research

Mr Ira Deveson

Representing the cancer genome with synthetic DNA spike-in controls

$448,200

Garvan Institute of Medical Research

Dr David Herrmann

Pinpointing the pro-invasive plasticity of breast cancer in vivo by targeting the Src/EMT signalling axis

$600,000

Garvan Institute of Medical Research

Mrs Heloisa Helena Milioli

Expanding the repertoire of therapies targeting sex steroid receptors in breast cancer

$600,000

Garvan Institute of Medical Research

Dr Max Nobis

Intravital imaging using AKT and DNA damage biosensor mice for drug target validation to improve PARP and PI3K inhibition in pancreatic cancer

$600,000

Macquarie University

Dr Andrew Care

Biological nanoparticles for targeted and light-controllable anticancer drug delivery

$367,010

The University of Sydney

Dr Noa Lamm-Shalem

Targeting novel pathways in the DNA replication-stress response to kill cancer

$599,135

The University of Sydney

Dr Alexander Sobinoff

Targeting telomeric repeat-binding factor 2 (TRF2) with small molecule inhibitors to promote a DNA damage response and prevent cancer cell growth

$568,816

The University of Sydney

Dr Alexander Menzies

Predictive biomarkers of response to immunotherapy in melanoma

$90,000

The University of Sydney

Dr Doan Trang Nguyen

Widely accessible high precision radiotherapy with Multi-modal Adaptive Tumour Tracking (MATT)

$393,606

The University of Sydney

Dr Ulf Schmitz

Cooperating microRNAs for cancer therapy - a systems medicine approach

$600,000

University of Newcastle

Dr Mengna Chi

Novel therapeutic applications for low THC containing medicinal hemp

$600,000

University of Newcastle

Dr Heather Lee

Single-cell analysis for improved epigenetic therapy in acute myeloid leukaemia

$538,000

University of New South Wales

Dr Frances Byrne

Developing new drugs that selectively kill cancer cells by targeting the Warburg Effect

$590,041

$6,594,808

2016

Career Development Fellowships

Administering Institution Fellow Title Amount (excl. GST)

Garvan Institute of Medical Research

Dr Marina Pajic

Immune modulators and anti-invasive treatments for pancreatic cancer: a new therapeutic partnership

$150,000

Garvan Institute of Medical Research

Dr David Gallego Ortega

The challenge of tumour heterogeneity, harnessing single cell molecular phenotype capacity

$597,118

Cancer Council NSW

Dr Natalie Taylor

Hide and seek with hereditary cancer: Translating evidence into practice to identify colorectal cancer patients with a high risk of Lynch syndrome

$598,251

University of New South Wales

Dr Orazio Vitorio

An anticancer chemically-modified natural compound targeting copper in neuroblastoma

$150,000

University of Newcastle

Dr Lei Jin

Overcoming resistance of metastatic melanoma to treatment with a focus on targeting a novel survival signaling pathway

$150,000

University of Newcastle

Dr Simon Keely

Investigating the role of hypoxia in tumour biology and microbiota interactions using a novel orthotopic model of colorectal cancer

$587,136

$2,382,505

Early Career Fellowships (ECF)

Administering Institution Fellow Title Amount (excl. GST)

Garvan Institute of Medical Research

Dr Angela Chou

Biomarker-driven preclinical trial of of pancreatic cancer defines a CDK4/6 inhibitor responsive molecular subtype

480,000

University of New South Wales

Dr Daniel Carter

Investigating MYCN-driven mitotic deregulation in neuroblastoma

$571,338

University of New South Wales

Dr Pei Yan Liu

Eradication of neuroblastoma by targeting a novel long non-protein-coding RNA

$576,000

University of New South Wales

Dr Dominik Beck

Long non-coding RNA expression improves the risk profiling and treatment outcomes for patients with Acute Myeloid Leukaemia

$549,039

University of New South Wales

Dr Ying Zhu

Rapid isolation and analysis of circulating exosomes using label-free nanoplasmonic sensors for non-invasive breast cancer diagnostics

$572,268

University of Newcastle

Dr Matthew Dun

Targeting activated signalling and oxidative stress pathways in acute myeloid leukaemia

$150,000

University of Sydney

Dr Chun-Chien Shieh

Real-time In-vivo Imaging during Lung Cancer Radiotherapy

$389,686

University of Sydney

Dr Emily Colvin

Evaluation of lysyl oxidase inhibitors as a new treatment for ovarian cancer

$150,000

University of Sydney

Dr Holly Bolton

Improving leukaemia therapy through prevention of graft-versus-host disease

$576,000

University of Sydney

Dr Megan Best

Overcoming psychosocial and ethical issues in cancer genomics: Translating test results into behavioural change

$564,666

University of Sydney

Dr Kristina Cook

Losing Sleep Over Cancer: Regulation of HIF-1 in Sleep Apnoea and Tumour Development

$597,219

University of Sydney

Miss Maiken Lise Marcker Espersen

Clinical proteomics and personalised treatment in ovarian cancer

$416,665

$5,592,881

2015

Future Research Leader Fellowships

The Cancer Institute NSW Future Research Leader Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.
ID Recipient Project Title Administering Institution Translational Cancer Research Centre/Unit Funded

2015/FRL101

 

Dr Mark Polizzotto

Immune modulatory agents in people with HIV and cancer: prevention, treatment, and implications for HIV eradication

The University of New South Wales

Translational Cancer Research Network

$796,305

2015/FRL106

 

Dr Mark Larance

Nutrient Deprivation and the Protective Proteome for the Prevention of Disease

The University of Sydney

Sydney Catalyst

$1,000,000

$1,796,305

Career Development Fellowships

Fulltime Fellowship to provide salary and project support to encourage the very best researchers (up to five years post doc) to choose cancer as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)
ID Recipient Project Title Administering Institution Funded

2015/CDF102

Dr Joshua McCarroll

Nanomedicine-based treatment to inhibit lung cancer growth and metastases

The University of New South Wales

$150,000

2015/CDF107

Dr Lenka Munoz

Dual targeting of EGFR for efficacious glioblastoma therapy

University of Sydney

$592,791

2015/CDF108

Dr Loretta Lau

Towards a therapy for aggressive cancers that lack a telomere maintenance mechanism

Sydney Children’s Hospitals Network (Randwick & Westmead) inc. The Royal Alexandra Hospital for Children

$600,000

2015/CDF110

A/Professor David Smith

Fifteen year quality of life, survivorship and survival outcomes for prostate cancer: The NSW Prostate Cancer Care and Outcomes Study (PCOS-15)

Cancer Council NSW

$569,128

2015/CDF111

Dr Nadeem Omar Kaakoush

The role of microbes in inflammation and metaplasia within the oesophageal adenocarcinoma cascade

The University of New South Wales

$593,269

2015/CDF114

 

Associate Professor Anne Cust

Epidemiological and intervention translational research to improve melanoma prevention and survivorship outcomes

University of Sydney

$87,500

$2,592,688

 

Early Career Fellowships

Fulltime Fellowship to provide salary and possible project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)

2015/ECF102

Dr Duohui Jing

Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic mechanism linked to basic DNA structure

The University of New South Wales

$606,479

2015/ECF108

Dr Angelica Marie Merlot

Pharmacological Targeting Approach for Novel Anti-Cancer Chemotherapeutics Implementing Innovative Albumin-Based Nanoparticles

University of Sydney

$450,000

2015/ECF111

Dr Phillip Fromm

Therapeutic Vaccination for Prostate Cancer using mRNA Loaded Blood Dendritic Cells

Anzac Research Institute

$566,445

2015/ECF113

Dr Ben Roediger

Single cell analysis as a diagnostic and prognostic approach in systemic mastocytosis

University of Sydney

$600,000

2015/ECF117

Dr Elizabeth Hinde

Nuclear delivery of DNA chemotherapeutics by pathogen shaped nanoparticles

The University of New South Wales

$416,690

2015/ECF138

Dr Seong Beom (Charlie) Ahn

Next Generation Colorectal Cancer Biomakers and Treatment

Macquarie University

$574,266

2015/ECF144

Dr Flora Tzelepis

A randomised controlled trial of the effectiveness of real-time video counselling on smoking cessation in smokers residing in regional and remote areas

University of Newcastle

$592,843

2015/ECF152

Dr Gillian Gould

Improving strategies for the management of smoking cessation in NSW pregnant Aboriginal women: the Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy Trial

University of Newcastle

$450,000

2015/ECF157

Dr James Wilmott

Identifying novel therapeutic targets for the treatment of melanoma in adolescents and young adults

University of Sydney

$429,481

$5,128,340

2014

Career Development Fellowships

Fulltime Fellowship to provide salary and project support to encourage the very best researchers (up to five years post doc) to choose cancer as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)

 

ID Recipient Project Title Administering Institution Funded

14/CDF/1–to16

 

Dr Jiang Chen

University of Newcastle

Overcoming Resistance of Metastatic Melanoma to treatment: MicroRNA-dependent expression of INPP4B as a biomarker and therapeutic target in melanoma

$598,176

14/CDF/1–to17

Dr Nikola Bowden

University of Newcastle

Investigation of the DNA repair protein XPC in melanoma treatment resistance.

$600,000

14/CDF/1–to21

Dr Pradeep Tanwar

University of Newcastle

Targeting chemoresistant ovarian cancer cells

$508,396

14/CDF/1–to25

Associate Professor Karen Canfell

University of New South Wales

Health economic evaluation of new approaches to screening for cancers of the cervix, prostate, colorectum and lung.

$594,000

Early Career Fellowships

Fulltime Fellowship to provide salary and possible project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)

 

14/ECF/1–to02

Dr Alexander Menzies

University of Sydney

Identifying predictive biomarkers of current systemic therapies and the discovery of new targets and future treatments to improve survival in metastatic melanoma.

$360,000

14/ECF/1–to06

Dr Michael Marinovich

University of Sydney

Evidence translation in breast cancer surgical planning

$324,000

14/ECF/1–to11

Dr Ursula Sansom-Daly

University of New South Wales

Novel approaches to address barriers to care among adolescents and young adults with cancer: Intervention research targeting vulnerable populations.

$179,796

14/ECF/1–to12

Dr Wing Hin Lee

University of Sydney

Inhalable paclitaxel loaded-iron oxide nanoparticle for lung cancer therapy

$592,183

14/ECF/1–to23

Dr Ruth Pidsley

Garvan Institute of Medical Research

The next-generation in prostate cancer biomarkers: using epigenetics to distinguish high-risk from low-risk disease

$597,651

14/ECF/1–to46

Dr Ryan Courtney

University of New South Wales

Reducing tobacco smoking among low-ses smokers: A RCT to improve compliance with treatment, smoking cessation and health economic outcomes

$558,512

14/ECF/1–to57

Dr Andrew Hutchinson

University of Technology, Sydney

Preclinical assessment of phosphatidylserine targeting monoclonal antibodies in multiple myeloma.

$590,500

2013

Early Career Fellowships

Fulltime Fellowship to provide salary and project support to encourage the very best researchers (up to five years post doc) to choose cancer as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)

13/ECF/1–to01

Dr Orazio Vittorio

Dextran-Catechin conjugation with SPIONs: a potential targeted therapy against gliobastoma multiforme.

University of New South Wales

$600,000

13/ECF/1–to02

Dr Morten Thaysen Andersen

The functional role of human CD147 N-glycosylation in cancer development using a hepatocellular carcinoma model system.

Macquarie University

$599,391

13/ECF/1–to03

Dr Vanessa Sequeira

Targeting melanoma with a novel class of anti-actin compounds.

University of New South Wales

$600,000

13/ECF/1–to04

Dr Andreia Pinho

Unravelling the role of the Slit/Robo signalling pathway in pancreatic tumourigenesis.

Garvan Institute of Medical Research

$597,462

13/ECF/1–to07

Dr Maarit Laaksonen

The burden of cancer - prevention, treatments, and costs.

University of New South Wales

$396,175

13/ECF/1–to08

Dr George Sharbeen

Base Excision Repair as a Therapeutic Target in Pancreatic Cancer.

University of New South Wales

$600,000

13/ECF/1–to09

Dr Lindsay Wu

Calorie restriction mimetics for the treatment of hepatocellular carcinoma.

University of New South Wales

$594,451

13/ECF/1–to10

Dr Anne Sugetha Vanniasinghe

Targeting mitochondria and lipid metabolism as novel therapeutic approach in Diffuse Intrinsic Pontine Glioma.

University of New South Wales

$427,816

13/ECF/1–to11

Dr Megan Passey

Reducing tobacco harm among groups with high smoking prevalence.

University of Sydney

$597,824

13/ECF/1–to13

Dr Justin Wong

Linking mutations and epigenetic silencing of splicing factors to aberrant splicing in acute myeloid leukaemia.

University of Sydney

$600,000

13/ECF/1–to15

Dr John Kipritidis

On-line ventilation imaging to reduce toxicity in lung cancer radiotherapy.

University of Sydney

$552,883

13/ECF/1–to16

Dr Sarah Hayes

Identification of predictive biomarkers of treatment response in Non-Small Cell Lung Cancer patients.

University of Sydney

$599,347

13/ECF/1–to17

Dr Kimberley Kaufman

Mechanisms of tumourrecurrence and chemotherapy escape in glioblastoma multiforme.

University of Sydney

$535,000

13/ECF/1–to25

Dr Maté Biro

Mechanobiology of cellular protrusions and the actomyosin cortex in invasive tumour cell migration.

University of Sydney

$600,000

13/ECF/1–to33

Dr Lei Jin

RIPK1 as a novel therapeutic target in melanoma.

University of Newcastle

$592,459

13/ECF/1–to34

Dr Matthew Dun

Identifying novel therapeutic targets for the treatment of Acute Myeloid Leukaemia.

University of Newcastle

$600,000

13/ECF/1–to37

Dr Allison Boyes

Supportive care in the digital age: Harnessing new technologies to improve adjustment to haematological cancer.

University of Newcastle

$501,553

13/ECF/1–to39

Dr Kimberley Beaumont

Rab27a as a novel therapeutic target: Investigating the role of Rab27a in melanoma growth and invasion.

University of Sydney

$568,974

13/ECF/1–to45

Dr Brian Gloss

Short-phase transcriptional programs in mammalian development influence cancer biology.

Garvan Institute of Medical Research

$584,458

13/ECF/1–to46

Dr Mark Cowley

Tumour evolution, and early detection of breast cancer empowered by massively parallel sequencing and in vivo imaging

Garvan Institute of Medical Research

$600,000

Career Development Fellowships

Fulltime Fellowship to provide salary and possible project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)

13/CDF/1–to01

Dr Marina Pajic

From functional genomics to precision medicine: The therapeutic potential of targeting ROCK signalling in pancreatic cancer.

Garvan Institute of Medical Research

$150,000

13/CDF/1–to03

Dr Goli Samimi

Development of a Blood-Based DNA Methylation Assay for Detection of High Grade Serous Ovarian Cancer in High Risk Women.

Garvan Institute of Medical Research

$600,000

13/CDF/1–to05

Dr Catherine Caldon

Synergy between proliferation defects and DNA damage in cancer.

Garvan Institute of Medical Research

$449,532

13/CDF/1–to09

Dr Yu Zheng

Characterization and Functional Analysis of the Vitamin D Receptor Isoforms and their Role in Breast Cancer Progression: Experimental and Human Translational Studies.

ANZAC Research Institute

$594,000

Future Research Leader Fellowships

The Cancer Institute NSW Future Research Leader Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.
ID Recipient Project Title Administering Institution Funded

13/FRL/1–to02

Dr David Croucher

Mapping and manipulating therapeutically induced JNK network architecture to tackle breast cancer chemoresistance.

Garvan Institute of Medical Research

$1,157,608

13/FRL/1–to03

Dr Tara Roberts

Understanding the role of SMG1 as a tumour suppressor.

University of Western Sydney

$1,225,257

Early Career Fellowships

Fulltime Fellowship to provide salary and project support to encourage the very best researchers (up to five years post doc) to choose cancer as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)
ID Recipient Project Title Administering Institution Funded

12/ECF/2–to15

Dr Peter Kelly

Cancer prevention in marginalised populations: a randomised controlled trial of a multiple risk factor reduction program.

University of Wollongong

$594,110

12/ECF/2–to17

Dr Zaklina Kovacevic

Targeting the metastasissuppressor NDRG1 for the treatment of pancreatic cancer

University of Sydney

$455,394

12/ECF/2–to33

Dr Phillippa Taberlay

De-looping DNA loops using epigenetic cancer therapies

Garvan Institute of Medical Research

$582,876

12/ECF/2–to08

Dr Katie Dixon

Novel vitamin D-like compounds to reduce DNA and other molecular damage after UV radiation

University of Sydney

$600,000

12/ECF/2–to04

Dr Emily Colvin

Characterising the tumour microenvironment of epithelial ovarian cancer

University of Sydney

$599,215

12/ECF/2–to34

Dr Bente Talseth-Palmer

Identification of genetic factors of inherited colon cancer

University of Newcastle

$599,798

Career Development Fellowships

Fulltime Fellowship to provide salary and possible project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years)
ID Recipient Project Title Administering Institution Funded

12/CDF/2–to26

Dr Hilda Pickett

Molecular mechanisms of telomere length control

Children's Medical Research Institute

$599,110

12/CDF/2–to28

Dr William Ritchie

Small non-coding RNAs control alternative splicing in Chronic Myeloid Leukaemia

University of Sydney

$600,000

12/CDF/2–to25

A/Prof Sallie-Anne Pearson

Post-market surveillance of cancer medicines: Generating evidence for clinical and policy practice using linked health administrative data

University of Sydney

$150,000

12/CDF/2–to03

Dr Linda Bendall

Microenvironmental Impact in the Treatment of Acute Lymphoblastic Leukaemia

University of Sydney

$150,000

12/CDF/2–to13

Dr Jeremy Henson

Using the CC DNA biomarker to investigate the regulation of ALT, develop a blood test for ALT+ cancer activity and develop ALT targeted cancer therapies

Children's Medical Research Institute

$150,000

12/CDF/2–to23

Dr Umaimintha Palendira

Mechanisms that control oncogenic Epstein Barr virus infection and their dysregulation in immunodeficiency

Garvan Institute of Medical Research

$598,533

Future Research Leader Fellowships

The Cancer Institute NSW Future Research Leaders Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.
ID Recipient Project Title Administering Institution Funded
11/FRL/3–to02 Dr James Rae Genetic Predictors of Anti-Estrogen Clinical Activity in Breast Cancer Patients. Garvan Institute of Medical Research $1,250,000
11/FRL/3–to03 Dr Eric Collisson Integrative Modeling and Targeting of Genomic Anomalies in Pancreatic Ductal Adenocarcinoma. Garvan Institute of Medical Research $1.249,935
11/FRL/5–to02 Dr Anthony Cesare Targeting TRF2 function to prevent cancer cell growth. Children's Medical Research Institute $1,218,795

Career Development Fellowships

Fulltime Fellowship to provide salary and possible project support to encourage the very best researchers to continue independent cancer research that is nationally and internationally competitive (max $200,000 p.a. x 3 years).
ID Recipient Project Title Administering Institution Funded
11/CDF/3–to05 A/Prof Tracy Bryan Structural and functional analyses of telomerase, a major anti-cancer target Children's Medical Research Institute $300,000
11/CDF/3–to25 Dr Tim Molloy Micro-RNA regulation or radiotherapy resistance in cancer Garvan Institute of Medical Research $597,984
11/CDF/3–to26 Prof Elizabeth Musgrove Using functional genomics in breast and pancreatic cancer to define and refine targeted therapies and identify potential cell cycle regulatory oncogenes Garvan Institute of Medical Research $150,000
11/CDF/3–to38 Dr Jenny Yingzi Wang Linking Wnt signalling and epigenetic regulation of tumour suppressors - developing novel epigenetic therapies against AML University of New South Wales $600,000
11/CDF/3–to39 Prof Wolfgang Weninger Real time visualisation of tumor associated-antigen specific T cell behaviour in vivo University of Sydney $600,000
$2,247,984

Early Career Development Fellowships

Fulltime Fellowship to provide salary and project support to encourage the very best researchers (up to five years postdoc) to choose cancer research as their career and to continue independent research that is nationally and internationally competitive (max $200,000 p.a. x 3 years).
ID Recipient Project Title Administering Institution Funded
11/ECF/3–to01 Dr David Chang Novel Biomarker Guided Therapeutic Strategies for Pancreatic Cancer Garvan Institute of Medical Research $365.491
11/ECF/3–to18 Dr Elizabeth Iorns Identifying and characterizing genes that regulate breast tumorigenesis Garvan Institute of Medical Research $600,000
11/ECF/3–to43 Dr Claire E Wakefield Prevention and management of psychological distress in families affected by paediatric cancer University of New South Wales $577,535
$1,543,026

Tags:

Grants